Attached files
file | filename |
---|---|
EX-99.1 - ADDITIONAL EXHIBITS - H-CYTE, INC. | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of
Report (Date of earliest event reported): February 17,
2017
MEDOVEX CORP.
(Exact
Name of Registrant as Specified in Charter)
Nevada
|
|
333-198621
|
|
46-3312262
|
(State
or other jurisdiction of
incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
|
|
|
|
|
3279
Hardee Avenue
Atlanta,
Georgia
|
|
|
|
30341
|
(Address
of principal executive offices)
|
|
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (844) 633-6839
Copies
to:
Harvey
Kesner, Esq.
Arthur
S. Marcus, Esq.
Sichenzia
Ross Ference KesnerLLP
61
Broadway, 32nd Floor
New
York, New York 10006
(212)
930-9700
(212)
930-9725 (fax)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d 2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
FORWARD-LOOKING STATEMENTS
This
Current Report on Form 8-K contains forward-looking statements.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to (i) securing
capital for general working purposes, and (ii) other risks and in
statements filed from time to time with the Securities and Exchange
Commission (the “SEC”). All such forward-looking
statements, whether written or oral, and whether made by or on
behalf of the Company, are expressly qualified by the cautionary
statements and any other cautionary statements which may accompany
the forward-looking statements. In addition, the Company disclaims
any obligation to, and will not, update any forward-looking
statements to reflect events or circumstances after the date
hereof.
Item 7.01 Regulation FD
Disclosure
On
February 15, 2017, MedoveX Corp. (the “Company”) issued a press release
(the “Release”)
regarding the status of its CE Mark approval. A copy of
the Release is attached hereto and incorporated herein by reference
in its entirety as Exhibit
99.1.
The
information contained in this Current Report on Form 8-K shall not
be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the
“Exchange Act”),
or incorporated by reference in any filing under the Securities Act
of 1933, as amended (the “Securities Act”) or the Exchange
Act, except as shall be expressly set forth by specific reference
in such a filing. The furnishing of the information in
this Current Report on Form 8-K is not intended to, and does not,
constitute a representation that such furnishing is required by
Regulation FD or that the information contained in this Current
Report on Form 8-K constitutes material investor information that
is not otherwise publicly available.
The
Securities and Exchange Commission encourages registrants to
disclose forward-looking information so that investors can better
understand the future prospects of a registrant and make informed
investment decisions. This Current Report on Form 8-K and exhibits
may contain these types of statements, which are
“forward-looking statements” within the meaning of the
Private Securities Litigation Reform Act of 1995, and which involve
risks, uncertainties and reflect the Registrant’s judgment as
of the date of this Current Report on Form 8-K. Forward-looking
statements may relate to, among other things, operating results and
are indicated by words or phrases such as “expects,”
“should,” “will,” and similar words or
phrases. These statements are subject to inherent uncertainties and
risks that could cause actual results to differ materially from
those anticipated at the date of this Current Report on Form 8-K.
Investors are cautioned not to rely unduly on forward-looking
statements when evaluating the information presented
within.
Item 9.01 Financial Statements and
Exhibits
(d) Exhibits.
Exhibit No.
|
|
Description
|
99.1
|
|
Press
Release dated February 15, 2017
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
MEDOVEX CORP.
|
|
|
|
|
Date:
February 17, 2017
|
By:
|
/s/ Jarrett Gorlin
Jarrett
Gorlin
Chief
Executive Officer
|